Perbedaan Fuji Finance Indonesia Tbk. dan Organon Pharma Indonesia Tbk.: Fuji Finance Indonesia Tbk. diperdagangkan di Rp246 (kapitalisasi pasar 317,2 M, volume 24 jam 749,4 rb), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Fuji Finance Indonesia Tbk. jauh lebih besar — sekitar 3× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| FUJI | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 317,2 M | 104,4 M |
Volume | 749,4 rb | — |
Lot | 7,49 rb | — |
Perputaran | 185,25 jt | — |
Harga Rata-rata | 247,19 | — |
Nilai Transaksi | 185,25 jt | — |
Harga Ekuilibrium Indikatif | 246 | — |
Volume Ekuilibrium Indikatif | 490 | — |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Fuji Finance Indonesia Tbk (Company) was established first with the name of PT Jaya FajarLeasing Pratama based on Notarial Deed of Kartini Muljadi S.H., No. 287 on September 211982, which was changed to Jaya Fuji Leasing Pratama on March 28, 1983, then on July 2018 the Company's name was changed to Fuji Finance Indonesia
Selengkapnya di halaman FUJI →PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →